SaiGon - Hanoi Securities Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	9.4yrs

Recent management updates

Recent updates

CEO

SaiGon - Hanoi Securities has no CEO, or we have no data on them.

Board Members

Name	Position	Tenure	Compensation	Ownership
Khoa Le	Director	11.2yrs	no data	0% ₫ 0
Tien Vu	Vice President of the Board	9.7yrs	no data	no data
Luu Luong	Supervisory Board Member	9.1yrs	no data	0% ₫ 0
Hong Pham	Head of Supervisory Board	16.3yrs	no data	no data
Trung Vu	Supervisory Board Member	12.1yrs	no data	0.33% ₫ 48.8b
Trinh Nguyen	Independent Director	4.3yrs	no data	0% ₫ 0
Vinh Do	Chairman of the Board	2.1yrs	no data	no data
Duc Luu	Director	2.1yrs	no data	no data

9.4yrs

Average Tenure

49yo

Average Age

Experienced Board: SHS's board of directors are considered experienced (9.4 years average tenure).

SaiGon - Hanoi Securities Management

Management criteria checks 1/4

Key information

Recent management updates

Less than half of directors are independent

Less than half of directors are independent

Recent updates

New minor risk - Share price stability

Full year 2023 earnings released: EPS: ₫688 (vs ₫238 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Full year 2023 earnings released: EPS: ₫966 (vs ₫221 in FY 2022)

Investor sentiment deteriorates as stock falls 22%

Third quarter 2023 earnings released: EPS: ₫245 (vs ₫138 in 3Q 2022)

Investor sentiment deteriorates as stock falls 17%

Second quarter 2023 earnings released: EPS: ₫173 (vs ₫494 loss in 2Q 2022)

First quarter 2023 earnings released: EPS: ₫50.00 (vs ₫810 in 1Q 2022)

Now 20% undervalued

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: ₫172 (vs ₫906 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Now 27% undervalued after recent price drop

Saigon - Hanoi Securities Joint Stock Company (HNX:SHS) acquired additional 5.9% minority stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company (HNX : PMC).

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₫1,132 (vs ₫642 in 3Q 2020)

Investor sentiment deteriorated over the past week

Inaugural dividend of ₫1,200 per share

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS ₫1,496 (vs ₫1,059 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ₫1,307 (vs ₫225 in 1Q 2020)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS ₫3,639

Investor sentiment improved over the past week

New 90-day high: ₫26,800

New 90-day high: ₫20,600

Investor sentiment improved over the past week

New 90-day high: ₫15,500

New 90-day high: ₫13,800

Third quarter earnings released

New 90-day high: ₫13,700

CEO

Board Members

Average Tenure

Average Age